产品英文名称 | COL4A1 Polyclonal Antibody |
免疫原 | 合成多肽:来源于N端的人源蛋白COL4A1. 氨基酸序列为: 30-110 |
宿主 | 兔 |
反应性 | 人, 小鼠 |
应用 | ELISA, IHC-P, WB |
实验建议 | 最佳的工作稀释比例需要客户摸索优化。建议的起始尝试的稀释比为:WB:1:500-1:2000,IHC-p:1:100-1:300,ELISA:1:20000。 尚未在其他应用中测试。 |
克隆性 | 多克隆 |
纯化工艺 | 使用表位特异性的免疫原,通过亲和层析,从兔抗血清中亲和纯化抗体。 |
产品形式 | 液体溶液 |
浓度 | 1 mg/ml |
储存缓冲液 | 含有50%甘油,0.5%BSA和0.02%叠氮化钠的PBS缓冲液。 |
保存建议 | 自发货之日起,-20°C可稳定保存1年。为最大限度的避免损失,请在打开管盖之前融化抗体并离心。我们建议使用前分装以避免反复冻融。 |
运输条件 | 蓝冰运输 |
警告 | 本文列出的产品仅供研究使用,不适用于人类或临床诊断。我们产品所推荐应用,不是建议使用我们的产品去违反任何专利或许可证。对于使用本产品可能发生的专利侵权或其他违规行为,我们不承担任何责任。 |
背景 | COL4A1 encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in COL4A1 cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. |
基因ID | 1282 |
别名 | COL4A1; Collagen alpha-1(IV) chain |
其它 | 该抗体可检测内源蛋白 |
蛋白质ID | P02462 |
Fig.1. Western Blot analysis of various cells using COL4A1 Polyclonal Antibody diluted at 1:500.
Fig.2. Western Blot analysis of rat-musle cells using COL4A1 Polyclonal Antibody diluted at 1:500.
微信公众号
评价
目前还没有评论